ArticleCancer causes & control : CCC2025
Sleep duration and the risk of epithelial ovarian cancer.
Article in Cancer causes & control : CCC, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
purposeVariations in sleep duration have been linked to biological mechanisms that may affect cancer risk. We investigated the association between sleep duration during adult life and the risk of epithelial ovarian cancer overall, and according to tumor behavior and invasive cancer type, in a population-based case-control study.
methodsAmong 465 cases and 855 controls, sleep duration during life periods starting at age 20 years was assessed, with which average sleep during adult life was calculated. Unconditional multivariable logistic regression was used to estimate odds ratios (OR) and 95% confidence intervals (CI). Polytomous logistic regression was used to estimate associations by tumor behavior (invasive vs. borderline) and invasive cancer type (Type I vs. II).
resultsCompared to an average sleep duration during adult life of the recommended 7-9 h/night, the ORs (95% CI) for ovarian cancer overall were 1.04 (0.74-1.46) and 1.78 (1.15-2.75) for < 7 and > 9 h/night, respectively. An increased risk with > 9 h/night was also observed for invasive and borderline tumors and among Type I and Type II invasive cancer types.
conclusionThe results suggest that sleep durations longer than the recommended 7-9 h/night during adulthood may be associated with an increased ovarian cancer risk.
Indexed as
Identifiers
40908349What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.